Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 56
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
220 Patients or 20,000? Clinics Split on Psychedelics’ First Year
Robert Rush: Emergency Scheduling, 7-OH, and the War on Research
Breaking: Compass Files Psilocybin for TRD New Drug Application with FDA
The Problems We Will Be Lucky to Have
Pα+ Psychedelic Bulletin #234: Psychedelics After the Midterms; FDA Answers House Psychedelics Caucus; ICER to Review Compass’ Psilocybin; Terran v. Compass Gets Trial Date
Is Cannabis Psychedelic? Examining the Scientific Evidence
Backed by $15m in NIDA Funding, NYU and B.More Team Up...
Compass Pathways Pushes Back Phase 3 Readouts, Lays Off 30% of...
Philosophy and Psychedelics: Can Metaphysics Bring Meaning to Non-Ordinary States?
The Business of Psychedelics with Joe Moore and Jaime Fiorucci
Final Stretch for Question 4: Controversy, Advocacy, and Celebrity Voices Shape...
The Penn Psychedelics Collaborative and the Power of Interdisciplinary Connections
Pα+ Psychedelic Bulletin #178: VA Funding of Lykos Phase 3 ‘Definitely...
Natural Medicine Advisory Bulletin 14
Meet the Legal Team Fighting the DEA to Save Psychedelic Research
Load more